Greg Martin
Chief Financial Officer
Replay available
Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2025 Earnings Call
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) Q4 2025 earnings conference call, held 2026-02-25. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Tom McCourt
Chief Executive Officer
Mike Schetzlein
Chief Medical Officer
Tammy Gaskins
Chief Commercial Officer
Jason Butler
Analyst, Citizens
Chase Knickerbocker
Analyst, Craig-Hallum
Amy Lee
Analyst, Jefferies
Mohit Bansal
Analyst, Wells Fargo
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ironwood Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.908 -- 00:00:05.334 Thank you for standing by. My name is Liz and I'll be your conference operator today. 00:00:05.334 -- 00:00:10.341 At this time, I'd like to welcome everyone to the Ironwood Pharmaceuticals Q4 and 00:00:10.341 -- 00:00:13.125 full year 2025 investor 00:00:13.125 -- 00:00:17.691 update conference call. All lines have been placed on mute to prevent any background 00:00:17.691 -- 00:00:22.197 noise. After the speaker's remarks, there will be a question and answer session. 00:00:22.197 -- 00:00:26.489 If you would like to ask a question during this time, simply press star followed by the 00:00:26.489 -- 00:00:30.815 number one on your telephone keypad. If you would like to withdraw your question, press 00:00:30.815 -- 00:00:35.582 star one again. Thank you. I would now like to turn the call over to Greg Martin, Chief 00:00:35.582 -- 00:00:39.104 Financial Officer. Please go ahead. 00:00:39.327 -- 00:00:43.512 Good morning, and thank you for joining us for our fourth quarter and full year 2025 00:00:43.512 -- 00:00:48.698 investor update. Our press release issued this morning can be found on our website. 00:00:48.698 -- 00:00:53.163 Today's call and accompanying slides include forward-looking statements within the meaning 00:00:53.163 -- 00:00:57.388 of the Private Securities Litigation Reform Act of 1995. 00:00:57.388 -- 00:01:01.532 Such statements involve risks and uncertainties that may cause actual results to differ 00:01:01.532 -- 00:01:06.137 materially. A discussion of these statements and risk factors is available on the current 00:01:06.137 -- 00:01:10.262 Safe Harbor Statement slide, as well as under the heading Risk Factors in our annual 00:01:10.262 -- 00:01:15.265 report on Form 10-K for the year ended December 31, 2024, 0...